Table 3.
Relative GPER protein and mRNA expression levels (GPER/GAPDH).
| Adenomyosis group (n = 42) | Control group (n = 34) | |||
|---|---|---|---|---|
| JZ | OM | JZ | OM | |
| Relative GPER protein expression levels | ||||
| PP | 1.12 ± 0.072b,c,e (n = 23) |
0.96 ± 0.043b,c,e (n = 23) |
0.95 ± 0.027a,c,e (n = 16) |
0.83 ± 0.051b,c,e (n = 16) |
| SP | 1.09 ± 0.076b,c,e (n = 19) |
0.94 ± 0.052b,c,e (n = 19) |
0.82 ± 0.097a,d,e (n = 18) |
0.84 ± 0.086b,d,e (n = 18) |
| Relative GPER mRNA expression levels | ||||
| PP | 1.52 ± 0.12b,c,e (n = 23) |
1.31 ± 0.09b,c,e (n = 23) |
1.28 ± 0.07a,c,e (n = 16) |
1.04 ± 0.1b,c,e (n = 16) |
| SP | 1.51 ± 0.14b,c,e (n = 19) |
1.29 ± 0.18b,c,e (n = 19) |
1.09 ± 0.13a,d,e (n = 18) |
1b,d,e (n = 18) |
Values expressed as mean ± standard deviation. aComparison between proliferative phase and secretary phase (same group and zone), p < 0.05, Student t-test; bcomparison between proliferative phase and secretary phase (same group and zone), p ≥ 0.05, Student t-test; ccomparison between outer myometrial zone and junctional zone (same group and phase) p < 0.05, Student t-test; dcomparison between outer myometrial zone and junctional zone (same group and phase) p ≥ 0.05, Student t-test; ecomparison between adenomyosis and control group (corresponding phase and zone) p < 0.05, Student t-test.